Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
JCO Precision Oncology|January 20, 2022
Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast CancerMarko Velimirovic, Dejan Juric, Andrzej Niemierko, et al.NPJ Breast Cancer|January 31, 2024
Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi techniqueEmily J Gallagher, Heather Moore, Mario E Lacouture, et al.JAMA Oncology|September 4, 2020
Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical TrialSara M Tolaney, Romualdo Barroso-Sousa, Tanya Keenan, et al.NPJ Precision Oncology|July 26, 2019
Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancerArielle J Medford, Taronish D Dubash, Dejan Juric, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2024
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast CancerAditya Bardia, Sheng Sun, Nayana Thimmiah, et al.Nature Medicine|January 21, 2025
Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2- breast cancer: a randomized phase 3 trialFatima Cardoso, Joyce O'Shaughnessy, Zhenzhen Liu, et al.International Journal of Radiation Oncology, Biology, Physics|May 18, 2020
Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation OncologistsAlice Y Ho, Jean L Wright, Rachel C Blitzblau, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2020
Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast CancerNeelima Vidula, Taronish Dubash, Michael S Lawrence, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2021
Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline UpdateBeverly Moy, R Bryan Rumble, Steven E Come, et al.Pageof 3